AZD6750 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

AstraZeneca1

Indications

Squamous Cell Carcinoma (Skin)1
Gastric Cancer, Gastroesophageal Junction Cancer1
High-grade Serous Ovarian Carcinoma1
Renal Cell Carcinoma1
Merkel Cell Carcinoma1

Grand Rapids, Michigan1 trial

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Research Site

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.